X3N
N~2~-{(4S,11aP)-2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-alaninamide
Find entries where: X3N
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | N~2~-{(4S,11aP)-2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-alaninamide |
Identifiers | (2~{S})-2-[[2-[(4~{S})-4-[bis(fluoranyl)methyl]-2-oxidanylidene-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide |
Formula | C18 H19 F2 N5 O4 |
Molecular Weight | 407.371 |
Type | NON-POLYMER |
Isomeric SMILES | C[C@@H](C(=O)N)Nc1ccc-2c(c1)OCCn3c2nc(c3)N4[C@@H](COC4=O)C(F)F |
InChI | InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1 |
InChIKey | SGEUNORSOZVTOL-CABZTGNLSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 48 |
Chiral Atom Count | 2 |
Bond Count | 51 |
Aromatic Bond Count | 11 |
Drug Info: DrugBank
DrugBank ID | DB15275 |
---|---|
Name | Inavolisib |
Groups | investigational |
Description | Inavolisib (GDC-0077) is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer). |
Synonyms |
|
Categories |
|
CAS number | 2060571-02-8 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 124173720 |
ChEMBL | CHEMBL4650215 |